National MS Society Invests $19 Million to Launch 40 New Multiple Sclerosis Research Projects to Drive Pathways to Cures
August 3, 2022
– Myelin repair, clues to MS progression, and wellness strategies are among the new leads being explored to move us closer to a world free of MS
The National Multiple Sclerosis Society has committed $19 million to launch 40 new multi-year research awards
to drive progress toward stopping MS, restoring function, and ending MS forever – the goals of the widely endorsed Pathways to Cures for MS
to better align the global MS research community around the most promising areas to cure MS for every single person as fast as possible.
The new awards include research training fellowships, early career awards, research grants and special initiatives. Just a few of the new cutting-edge projects include:
- Oregon Health & Science University researchers will investigate how to block signals that cause nerve cells to die in MS;
- Case Western Reserve researchers will seek new targets for treatments to repair damage to the nervous system in people with MS;
- A team at Johns Hopkins will test a potential treatment for MS-related fatigue;
- and University of California, San Francisco researchers will analyze immune cells in the spinal fluid of people with MS for clues to what triggers disease.
“The comprehensive nature of these new research awards is exciting and critical,” noted Cyndi Zagieboylo, President and CEO of the National MS Society. “Investments in research accelerate progress on our Pathways to Cures roadmap journey to stop MS disease activity, reverse symptoms and end MS forever. Through leadership, influence and funding, we will cure MS while empowering people affected by MS to live their best lives.”
This latest financial commitment is part of a projected total investment of nearly $30 million in 2022 to support more than 250 new and ongoing MS research studies around the world, including support and leadership for the International Progressive MS Alliance
– a global effort to accelerate the development of effective treatments for people with progressive MS to improve quality of life worldwide.
Learn more about Pathways to Cures for MS
Download details about the new research awards
Multiple sclerosis is an unpredictable disease of the central nervous system. Currently there is no cure. Symptoms vary from person to person and may include disabling fatigue, mobility challenges, cognitive changes, and vision issues. An estimated 1 million people live with MS in the United States. Early diagnosis and treatment are critical to minimize disability. Significant progress is being made to achieve a world free of MS.